BCG Vaccine Market to Witness Increasing Growth $28,051 thousand by 2023 at CAGR of 4.6% | Allied Market Research
BCG Vaccine Market by Demographics: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global BCG vaccine market was valued at from $20,366 thousand in 2016, and is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/4419
Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine currently available for prevention of tuberculosis (TB). One dose of BCG vaccine is recommended for healthy babies at birth in countries where tuberculosis is common.
The major factor that contributes to the market growth are increase in incidence rate of tuberculosis in developing nations, rise in R&D activities related to vaccines, and growth in government initiatives and focus on immunization programs globally. However, side reactions of BCG vaccines on patients and shortage of vaccine supply hinder the market growth. Moreover, untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.
The pediatrics segment is expected to maintain its dominant position during the analysis period, as the vaccine is administered to all the children at the time of birth. As BCG is recommended for only one dose; therefore, it is used rarely in the case of adults.
Key Findings of the BCG Vaccine Market:
- The pediatrics segment accounted for more than three-fourths share of the global market in 2016.
- China is expected to grow at a rapid CAGR of 6.2% from 2017 to 2023.
- India accounted for one-sixth of the global market in 2016.
- The adults segment is expected to grow at a CAGR of 3.6% from 2017 to 2023.
Get a purchase enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/4419
Leading market players: –
The major companies profiled in the report include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institut.
Similar Reports:
Animal Vaccines Market: Global Opportunity Analysis and Industry Forecast, 2018 – 2025
Cholera Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2018 – 2025
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States
Website: www.alliedmarketresearch.com/BCG-vaccine-market
